A competitive BB-ELISA for anti-toxin B neutralising antibodies in assessing risk of recurrent Clostridioides difficile infection: a retrospective cohort study from the MODIFY I and II trials. (linkinghub.elsevier.com)

Authors: Yu H … Feng H Journal: Lancet Microbe Published: 2026-09-30 DOI: https://doi.org/10.1016/j.lanmic.2026.101521